Compounds > benzyl glucopyranoside
Page last updated: 2024-08-02 18:16:21

benzyl glucopyranoside

Description

benzyl glucopyranoside: structure in first source [MeSH]

Cross-References

ID SourceID
PubMed CID11076492
SCHEMBL ID4866754
MeSH IDM0366339

Synonyms (9)

Synonym
benzyl glucopyranoside
34246-23-6
benzyl d-glucopyranoside
SCHEMBL4866754
1-o-benzyl-d-glucopyranose
GKHCBYYBLTXYEV-HENWMNBSSA-N
W-202397
(2r,3s,4s,5r)-2-(hydroxymethyl)-6-phenylmethoxyoxane-3,4,5-triol
(3r,4s,5s,6r)-2-(benzyloxy)-6-(hydroxymethyl)oxane-3,4,5-triol

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
4-hydroxybenzaldehyde
1
hydroxybenzaldehydeEC 1.14.17.1 (dopamine beta-monooxygenase) inhibitor;
mouse metabolite;
plant metabolite		2013201311.0low000010
thymine
1
pyrimidine nucleobase;
pyrimidone		Escherichia coli metabolite;
human metabolite;
mouse metabolite		2013201311.0low000010
phlorhizin
1
aryl beta-D-glucoside;
dihydrochalcones;
monosaccharide derivative		antioxidant;
plant metabolite		2005200519.0low000100
quinic acid
1
2004200420.0low000100
tiletamine hydrochloride
1
2000200024.0low001000
glucose, (beta-d)-isomer
6
D-glucopyranoseepitope;
mouse metabolite		2000201318.2high001320
prunasin
1
prunasin2001200123.0low000100
glycosides
2
2000200123.5medium001100
caffeic acid
1
caffeic acidgeroprotector;
mouse metabolite		2004200420.0low000100
chlorogenic acid
1
cinnamate ester;
tannin		food component;
plant metabolite		2004200420.0low000100
coniferin
1
aromatic ether;
cinnamyl alcohol beta-D-glucoside;
monosaccharide derivative		plant metabolite2000200024.0low001000
luteolin
1
3'-hydroxyflavonoid;
tetrahydroxyflavone		angiogenesis inhibitor;
anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
c-Jun N-terminal kinase inhibitor;
EC 2.3.1.85 (fatty acid synthase) inhibitor;
immunomodulator;
nephroprotective agent;
plant metabolite;
radical scavenger;
vascular endothelial growth factor receptor antagonist		2013201311.0low000010
syringin
1
beta-D-glucoside;
dimethoxybenzene;
monosaccharide derivative;
primary alcohol		hepatoprotective agent;
plant metabolite		2000200024.0low001000
ConditionIndicatedStudiesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
Alloxan Diabetes0
1
2012201212.0high000010
Hyperglycemia0
1
2012201212.0high000010
Hyperglycemia, Postprandial0
1
2012201212.0high000010